PICALM and Alzheimer disease: Further studies are thus necessary to decipher the potential abnormalities of PICALM post-translational modifications using 2D Western blot analyses and mass spectrometry from control and AD brain samples to search for AD-specific post-translational modifications of PICALM and their implications in pathology.